Constructing multiple test procedures for partially ordered hypothesis sets

Statistics in Medicine

Volumn 26, Issue 28, 2007, Pages 5116-5124

  Edwards, David ^a   Madsen, Jesper ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Closed test procedure; Familywise error rate; Fixed sequence test procedure; Hierarchical test procedure; P closed test procedure

Indexed keywords

ALGORITHM; ARTICLE; BIOSTATISTICS; CLINICAL RESEARCH; CONTROLLED STUDY; EXPERIMENTAL DESIGN; NULL HYPOTHESIS; PROBABILITY; SEQUENTIAL ANALYSIS; SYSTEMATIC ERROR;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 36348960216     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2905     Document Type: Article

References (20)

1. Hochberg Y, Tamhane A. Multiple Comparison Procedures. Wiley: New York, 1987.
2. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63(3):655-660.
3. Sonnemann E, Finner H, Kunert J. Analyse von Verlaufskurven. Biometriekurs, Universitet Trier, 1986.
4. Maurer W, Hothorn LA, Lemacher W. Multiple comparisons in drug clinical trials and preclinical assays: a priori ordered hypotheses. In Biometrie in der chemische-pharmazeutichen Industrie, Vollman J (ed.), vol. 6. Fischer Verlag: Stuttgart, 1995.
5. Ruberg SJ. Dose-response studies II: analysis and interpretation. Journal of Biopharmaceutical Statistics 1995; 5:15-42.
6. Westfall PH, Krishen A. Optimally weighted, fixed sequence, and gatekeeping multiple testing procedures. Journal of Statistical Planning and Inference 2001; 99:25-40.
7. Balakrishnan VK. Introductory Discrete Mathematics. Dover: New York, 1996.
8. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics 1987; 43:487-498.
9. Bauer P. Multiple testing in clinical trials. Statistics in Medicine 1991; 10:871-890.
10. Dmitrienko A, Molenberghs G, Chuang-Stein C, Often W. Analysis of Clinical Trials Using SAS: A Practical Guide, Chapter 2. SAS Institute: Carey, 2003.
11. Shaffer JP. Multiple hypothesis testing. Annual Review of Psychology 1995; 46:561-584.
12. Rosenthal R, Rubin DB. Ensemble-adjusted p-values. Psychological Bulletin 1983; 94:540-541.
13. Morikawa T, Yoshida M. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. Journal of Biopharmaceutical Statistics 1995; 5(3):297-306.
14. Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clinical trials. Journal of Royal Statistical Society, Series A 1996; 159(1):93-110.
15. Hsu JC, Berger RL. Stepwise confidence intervals without multiplicity adjustment for dose response and toxicity studies. Journal of American Statistical Association 1999; 94:468-482.
16. Dunnett CW. A multiple comparisons procedure for comparing several treatments with a control. Journal of American Statistical Association 1955; 60:573-583.
17. Shaffer JP. Modified sequentially rejective multiple test procedures. Journal of American Statistical Association 1986; 81:826-831.
18. Dmitrienko A, Often WW, Wesffall PH. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Statistics in Medicine 2003; 22:2387-2400.
19. Chen X, Luo X, Capizzi T. The application of enhanced parallel gatekeeping strategies. Statistics in Medicine 2005; 24:1385-1397.
20. Dmitrienko A, Often W, Wang O, Xiao D. Gatekeeping procedures in dose-response clinical trials based on the Dunnett test. Pharmaceutical Statistics 2006; 5:19-28.